Abstract
Eight integrin α-β heterodimers recognize ligands with an Arg-Gly-Asp (RGD) motif. However, the structural mechanism by which integrins differentiate among extracellular proteins with RGD motifs is not understood. Here, crystal structures, mutations and peptide-affinity measurements show that αVβ6 binds with high affinity to a RGDLXXL/I motif within the prodomains of TGF-β1 and TGF-β3. The LXXL/I motif forms an amphipathic α-helix that binds in a hydrophobic pocket in the β6 subunit. Elucidation of the basis for ligand binding specificity by the integrin β subunit reveals contributions by three different βI-domain loops, which we designate specificity-determining loops (SDLs) 1, 2 and 3. Variation in a pair of single key residues in SDL1 and SDL3 correlates with the variation of the entire β subunit in integrin evolution, thus suggesting a paradigmatic role in overall β-subunit function.
Integrins are α-β heterodimers that connect diverse extracellular ligands to the cytoskeleton and regulate cell growth and differentiation1. The primary function of most of the 24 vertebrate integrins is to mediate cell adhesion and migration; in contrast, integrins αVβ6 and αVβ8 are specialized to activate TGF-β1 and TGF-β3 (refs. 2,3). The similarity in phenotypes of mice deficient in TGF-β1 (ref. 4) to those of mice deficient in integrin αVβ6 (ref. 2) or αVβ8 (ref. 3) and to those of mice in which RGE in latent TGF-β1 (pro-TGF-β1) has replaced RGD5 demonstrates the importance of the RGD motif and integrins αVβ6 and αVβ8 in TGF-β1 activation in vivo. How integrins αVβ6 and αVβ8 achieve specificity, and how integrin β subunits in general contribute to ligand specificity, remain unclear. Little is known beyond mutational evidence for the importance of a disulfide-bonded loop (the β2-β3 loop) in the βI domain6 and the invariant binding of the metal ion–dependent adhesion site (MIDAS) to an acidic residue present in all integrin ligands7–10. The issue of how the β subunit contributes specificity is particularly acute for the five RGD-recognizing integrins that contain the αV subunit and differ only in having the β1, β3, β5, β6 or β8 subunit.
Here, we report the molecular mechanism by which αVβ6 achieves high specificity for the RGD peptide motif present in the prodomains of TGF-β1 and TGF-β3 and the determinants of specificity for integrin β subunits in general.
RESULTS
Pro-TGF-β1 activation correlates with high integrin affinity
Transfectants expressing αVβ6 and αVβ8 but not αV, cotransfected with the β1, β3 and β5 subunits, can activate pro-TGF-β (Fig. 1a), results in agreement with previous studies11. In correlation with activation, αVβ6 and αVβ8, but not other αV integrin transfectants, strongly bound 50 nM fluorescein isothiocyanate (FITC)-labeled pro-TGF-β1 (Fig. 1b).
Ligands bind to the integrin headpiece, which contains the α-subunit β-propeller domain and thigh domain as well as the β subunit βI, hybrid, PSI and EGF1 domains. There are no previous measurements of αVβ6 affinity for ligand despite the extensive characterization of specificity and comparison among TGF-β1, TGF-β2 and TGF-β3 and among integrins in adhesion and binding assays. αVβ6 can be affinity purified with both the TGF-β1 prodomain and fibronectin2. Adhesion assays and enzyme-linked immunosorbent assays have indicated stronger binding of αVβ6 than αVβ3 to pro-TGF-β1 and to pro-TGF-β3 and a lack of binding in the same assays to pro-TGF-β2 (refs. 2,12). We accurately measured the affinity of monomeric pro-TGF-β3 peptide GRGDLGRL for the αVβ6 and αVβ3 headpieces with fluorescence anisotropy, using either direct binding of FITC-labeled peptide or competition with unlabeled peptide. All measurements were with the physiologic cations Mg2+ and Ca2+. Nonapeptides containing RGD from pro-TGF-β1 and pro-TGF-β3 bound to αVβ6 with remarkably high affinity (10.3 and 8.5 nM, respectively; Fig. 1c). In contrast, the same peptides bound to αVβ3 with 1,000-fold-lower affinity (Fig. 1d). Interestingly, the homologous peptide from pro-TGF-β2, which has SGD in place of RGD, also bound to αVβ6 but with a 1,000-fold-lower affinity (8.5 µM) comparable to that of the GRGDSP peptide of fibronectin (2.5 µM; Fig. 1c). It is quite interesting that αVβ6 binds to pro-TGF-β2 peptide with an affinity that is in a range typically found for integrin binding to biological ligands. These results suggest that further investigation is warranted of a role for integrins, possibly distinct from that of αVβ6, in the activation of pro-TGF-β2.
αVβ6 crystal structures
We turned to crystal structures to determine the basis for the unprecedented high affinity of αVβ6 for pro-TGF-β and its peptides. Crystals of the αVβ6 headpiece, with or without a pro-TGF-β3 undecapeptide soaked in, diffracted to 2.6 and 2.85 Å (Table 1), respectively, and contained two molecules per asymmetric unit, with almost identical structures. The headpiece adopts the closed headpiece conformation in the absence and presence of soaked ligand (Fig. 2a), i.e., with the hybrid domain swung in toward the α subunit and with the β1-α1 and β6-α7 loops and α7 helix in the βI domain in the closed conformation8,13–15. Compared to those of β3, the βI and PSI domains of β6 are similar in structure, with greater differences in the hybrid domain (Supplementary Table 1).
Table 1.
αVβ6 | αVβ6 + TGF-β3 peptide | |
---|---|---|
Data collection | ||
Space group | C2 | C2 |
Cell dimensions | ||
a, b, c (Å) | 184.5, 168.3, 101.8 | 184.4, 170.0, 102.4 |
α, β, γ (°) | 90, 98.2, 90 | 90, 98.7, 90 |
Resolution (Å) | 50.0–2.85 (2.95–2.85)a | 50.0–2.60 (2.69–2.60) |
Rmerge | 17.5 (349) | 12.9 (198) |
I / σI | 4.8 (0.4) | 4.9 (0.5) |
CC½ (%)b | 98.2 (10.0) | 98.8 (18.3) |
Completeness (%) | 97.4 (83.0) | 96.4 (96.6) |
Redundancy | 2.4 (2.3) | 2.4 (2.4) |
Refinement | ||
Resolution (Å) | 50.0–2.85 | 50.0–2.60 |
No. reflections | 69,928 (4,837) | 91,038 (9,101) |
Rwork / Rfree | 23.6 (38.0) / 27.9 (41.7) | 21.4 (37.1) / 25.9 (37.3) |
CCwork / CCfree | 93.0 (29.5) / 91.0 (19.7) | 94.9 (39.1) / 92.6 (27.4) |
No. atoms | ||
Protein | 16,485 | 16,626 |
Ligand/ion | − /12 | 166/14 |
Water | 161 | 230 |
B factors | ||
Protein | 96.0 | 76.0 |
Ligand/ion | − /81.5 | 84.7/71.9 |
Water | 56.3 | 51.1 |
r.m.s. deviations | ||
Bond lengths (Å) | 0.005 | 0.009 |
Bond angles (°) | 0.76 | 1.3 |
Values in parentheses are for highest-resolution shell. The resolution for each crystal was determined at which CCfree of the highest-resolution shell for the finial model is about 20%.
Pearson’s correlation coefficient between average intensities of random half data sets for each unique reflection31.
Three closely spaced metal ion–binding sites are present in the integrin βI domain: the synergistic metal ion–binding site (SyMBS), the MIDAS and the site adjacent to the MIDAS (ADMIDAS). αVβ6 crystallized at pH 6.5 loses its SyMBS metal ion; furthermore, the SyMBS-coordinating α2-α3 loop also remodels and invades the ligand-binding pocket (Fig. 2b). Remodeling enables SyMBS residues Asn218 and Asp220 to point outward and to form three strong, 2.4- to 2.7-Å hydrogen bonds in place of Ca2+ coordination (Fig. 2b). Similar remodeling of the β3-subunit α2-α3 loop in the absence of a SyMBS Ca2+ (refs. 13,15) is blocked by the large side chains of residues that characterize its ligand-binding pocket, especially β3 Arg214 and Tyr166 in place of β6 Ala217 and Lys170 (Fig. 2f–h).
We hypothesized that crystallization at pH 4.5–6.5 might be responsible for variable loss of the SyMBS, MIDAS and/or ADMIDAS metal ions from αVβ3 (refs. 13,15) and αVβ6, in contrast to occupation of all three sites in αIIbβ3 crystalized at higher pH14,16. To test this hypothesis, we examined the effect of pH on affinity of αVβ6 for the TGF-β3 nonapeptide. Indeed, fluorescence anisotropy demonstrated strong pH dependence with a particularly sharp decrease in affinity between pH 7 and pH 6 (Fig. 2c). Because many cells coexpress integrins with their ligands, including epithelial cells that coexpress αVβ6 and pro-TGF-β1, it is possible that this pH dependence may contribute to the inhibition of ligand binding during biosynthesis in the Golgi (pH 6.0–6.7) and transport in endosomes (pH 6.3–6.5)17.
Ligand binding by αVβ6
Soaking ligand into crystals restored a Ca2+-bound conformation of the SyMBS α2-α3 loop (Fig. 2b) and revealed how the TGF-β3 peptide binds with high affinity (Fig. 2d). Simulated annealing composite omit maps show excellent ligand density (Supplementary Fig. 1). Ligand binding induced a local ~1.5-Å displacement of the β1-α1 loop toward the aspartate of RGD and the MIDAS Mg2+ (Fig. 2b), as seen in intermediate states of other integrins with soaked-in RGD7,9,13,16. Comparing the structure of ligand-bound αVβ6 with six intermediate states of integrin αIIbβ3 between closed (state 1) and open (state 8), we found that the ligand-bound β6 βI domain is similar to the intermediate state 2. In contrast, the ligand-free αVβ6 structure is clearly closed (state 1)14,16. The aspartate of RGD coordinated the MIDAS Mg2+ ion through one side chain oxygen and formed hydrogen bonds to NH groups of Asn218 and Ala126 through the other side chain oxygen (Fig. 2d). The arginine of RGD formed bidentate hydrogen bonds through its guanido group to the side chain of Asp218 in the αV β-propeller domain (Fig. 2d), as in binding to αVβ3 (Fig. 2e)7. Furthermore, as the ligand spanned the αV-β6 interface, the backbone of the RGD arginine formed a hydrogen bond to the side chain of Thr221 in the β6 α2-α3 loop (Fig. 2d). A similar hydrogen bond to the ligand backbone can form with β8 but not with β3 or β5, which have alanine in the position of β6 Thr221 (Fig. 2e,h).
The largest conformational difference in the ligand-binding region between αVβ6 and αVβ3 is in the β2-β3 loop. This loop is displaced in β6 relative to β3 as a consequence of sequence differences in both the β2-β3 loop itself and in the β1-α1 and α2-α3 loops with which it interacts (Fig. 2f–h). The path of the β2-β3 loop is altered in β3 by the insertion of cis-Pro169 (Fig. 2g,h) as well as by π-cation bonds between β2-β3 residue Tyr166 and α2-α3 residues Arg214 and Arg216 (Fig. 2g). The three residues forming π-cation bonds are replaced in β6 by Lys170, Ala217 and Ile219 (Fig. 2f). Furthermore, a hydrogen bond between Tyr185 in the β2-β3 loop and Asp129 in the β1-α1 loop constrains the conformation at the C-terminal portion of the β2-β3 loop in β6 (Fig. 2f). Thus, backbone differences in the β2-β3 loop derive not only from the difference in this loop’s own sequence but also from differences in the sequences of loops that interact with the β2-β3 loop.
Strikingly, the TGF-β3 peptide forms an α-helix that extensively interfaces with the β6 subunit (Fig. 2a,d). Immediately following the aspartate of RGD, the sequence 244-LGRLK-248 forms an amphipathic α-helix. TGF-β Leu244 binds in a β6-subunit hydrophobic pocket formed by the side chain of Ala217 and the backbone of Asn218 in the α2-α3 loop; the backbone of Pro179 and the side chains of Cys180 and Ile183 in the β2-β3 loop; and the side chain of Ala126 in the β1-α1 loop (Fig. 2d). The aliphatic portion of the ligand Lys248 side chain contributes to burying Leu244. Ligand residue Leu247 further buries Leu244 and binds in the same hydrophobic pocket by interacting with the backbone and side chain of Ala126 in the β1-α1 loop and with the side chain of Ile183, the disulfide bond of Cys177 and Cys184, and the aromatic ring of Tyr185 in the β2-β3 loop. Thus, three different loops in the βI domain make contacts with the TGF-β ligand (Fig. 2d).
Integrin β subunits vary markedly at the positions in the β1-α1 and α2-α3 loops where Ala126 and Ala217 contact the amphipathic TGF-β α-helix (Fig. 2h). Ala126, in the β6 123-DLSAS-127 MIDAS motif, is conserved in β8 but is a tyrosine in β3 (Tyr122; Fig. 2g) and in the β1, β2 and β7 subunits (Fig. 2h). Introduction of the tyrosine residue with the A126Y mutation substantially decreased both binding of pro-TGF-β1 and activation of TGF-β1 (Fig. 1a,b). Ala217 in the α2-α3 loop is a small residue (glycine or alanine) in most integrin β subunits but is a large arginine in the β3 and β5 subunits (Fig. 2h). The A217R and double A126Y A217R mutations completely abolished pro-TGF-β1 binding and activation (Fig. 1a,b).
Between the two disulfide-bonded cysteines in the β2-β3 loop, in which Ile183 and Tyr185 contact the pro-TGF-β α-helix, integrins are highly diverse6 (Fig. 2h). However, individual β6 I183Y and Y185S mutations had no effect, and the double mutation only slightly affected αVβ6 binding and activation of pro-TGF-β1 (Fig. 1a,b).
The integrin-binding loop in pro-TGF-β
In the ligand, the glycine residue preceding RGD extends back toward the amphipathic α-helix (Fig. 2d). Thus, Gly240 and Lys248 in 240-GRGDLGRLK-248 are only 8 Å apart (Fig. 2d). The sequence in between has an overall loop-like conformation, with Asp243 and Leu244 most buried in the binding pocket, which is centered on the β6 subunit rather than the αVβ6 interface (Fig. 2d). Because the two ends of the pro-TGF-β3 peptide are near each another and orient away from the integrin, the peptide complex is highly compatible with integrin binding to a pro-TGF-β3 macromolecule.
The integrin-binding residues identified here lie near the middle of an 18-residue segment that is disordered or only weakly ordered in the structure of pro-TGF-β1 (ref. 18) and can easily protrude from the shoulder region of pro-TGF-β to bind αVβ6 in the helical conformation identified here. Interestingly, foot-and-mouth disease virus (FMDV) uses an RGD motif followed by an amphipathic sequence very similar to those in pro-TGF-β1 and pro-TGF-β3 (Fig. 3a)19 to bind integrin αVβ6 and infect epithelial cells.
We tested the importance of the amphipathic α-helix for binding to αVβ6 by helix truncation and mutation, truncating the C terminus of the TGF-β3 undecapeptide one residue at a time (Fig. 3b). The largest stepwise drops in affinity, about ten-fold each, occurred when Leu244 and then Leu247 were removed (Fig. 3b), thus verifying the importance of these residues. To disrupt the α-helix conformation upon binding of pro-TGF-β1 to αVβ6, we mutated residues Ala220 and Thr221, which correspond to α-helix residues Gly245 and Arg246 in the pro-TGF-β3 peptide and have no contact with αVβ6, to proline. These mutations had no effect on pro-TGF-β1 expression (Fig. 3c), results consistent with the postulated lack of importance of this region for structural stability. However, the double-proline mutant was deficient in its ability to be activated by αVβ6 (Fig. 3d), thus supporting the importance of the α-helical conformation for interaction with pro-TGF-β1.
DISCUSSION
Specificity determinants of integrin β subunits
We have revealed specializations in an integrin β subunit that enable ligand recognition with high affinity and specificity. αVβ6 recognizes not only RGD but also an LXXL/I motif that folds into an amphipathic α-helix fitting into a hydrophobic pocket composed solely of residues from the β6 subunit. We observed these interactions with a TGF-β3 peptide bound to αVβ6 in an intermediate state. With mutations, we tested the importance of the observed interactions in binding and activation of macromolecular pro-TGF-β1 by αVβ6 on cell surfaces. These assays interrogate αVβ6 in the open conformation, because in the absence of crystal-lattice contacts, pro-TGF-β induces αVβ6 headpiece opening in the presence of Mg2+ and Ca2+ (ref. 18). Furthermore, we also measured binding in the presence of Mn2+, an activator of integrin headpiece opening20. These results confirmed the importance of contact residues in the β1-α1 loop and α2-α3 loops in pro-TGF-β1 binding to open αVβ6. Moreover, in the βI domain’s shifting to the open conformation, the α2-α3 and β2-β3 loops do not shift, and shifting in the β1-α1 loop (1.4 Å at Tyr122 in β3, equivalent to β6 A126) is insufficient to change contact residues8,16. Therefore, we conclude that the observations here on β6 residues that determine specificity for pro-TGF-β1 and pro-TGF-β3 are independent of integrin conformational state.
In contrast to our αVβ6 complex, complexes of αVβ3, αIIbβ3 and α5β1 have revealed little interaction beyond that with RGD itself7–9,16,21. The β6 hydrophobic-pocket interaction with the amphipathic α-helix revealed here enables αVβ6 to achieve ~1,000-fold selectivity for pro-TGF-β over the RGD motif present in fibronectin and ~1,000-fold selectivity over αVβ3 for recognition of pro-TGF-β.
The nanomolar affinity measured here is unprecedented for a monomeric integrin ligand and for a measurement in Mg2+ and Ca2+. By comparison, RGD peptides show, in Mg2+ and Ca2+, half-maximal effective concentration (EC50) values of 7 µM to 1 mM for αIIbβ3 (refs. 22,23) and half-maximal inhibitory concentration (IC50) values of 10–200 µM for αIIbβ3 (ref. 24) and 1–20 µM for αVβ3 (ref. 25). The resting affinity of integrin αLβ2 for its biological ligand is 700 µM (ref. 26). The 10-nM affinity of αVβ6 for ligand is thus unprecedented. Low integrin affinity is important to reverse adhesion in retracting regions of cells during cell migration27. The extraordinarily high affinity of αVβ6 may reflect a specialization to support activation of TGF-β rather than cell migration.
Previously, little had been known about the contribution of integrin β subunits to ligand recognition beyond that of the MIDAS. Our crystal structure shows that contacts with the amphipathic α-helix in the ligand, which confer high affinity for αVβ6, are mediated by the βI-domain β1-α1, β2-β3 and α2-α3 loops. Mutations demonstrated that β1-α1 and α2-α3 are important both for binding to pro-TGF-β1 and for its activation. The β2-β3 loop has previously been shown by mutation to be important for ligand selectivity by αVβ3 and αVβ1 (ref. 6) and has been designated a specificity-determining loop (SDL)28.
We propose to designate the β1-α1, β2-β3 and α2-α3 loops SDLs 1–3, according to their order in the amino acid sequence (Fig. 2d–h). In addition to contacting the amphipathic helix, the β1-α1 (SDL1) and α2-α3 (SDL3) loops contact the glycine and aspartate of RGD. The SDL designation for the three loops in the βI domain that bind ligand is analogous to the complementarity-determining region (CDR) designation for antibody and T cell–receptor chains, which also use three surface-exposed loops to contact ligand.
In the eight human integrin β subunits, SDL1 and SDL3 have the sequences D(V/L/F)SX1SMX2(D/N)(D/N) and (V/I)SX1NX2D(A/S/T)PE, respectively (Fig. 2h). The two alanines in β6 that contact pro-TGF-β are in the X1 position in each loop. Variation in the X1 positions of SDL1 and SDL3 correlates with variation in the entire β subunit through evolution (Fig. (2h and ref. 29), thus suggesting a paradigmatic role in overall β-subunit function. Thus, residues in the X1 positions in SDL1 and SDL3 (respectively alanine and alanine/glycine in the β6 and β8 subfamily; tyrosine and glycine in the β1, β2 and β7 subfamily; tyrosine/leucine and arginine in the β3 and β5 subfamily; and asparagine and glycine in β4) have a unique pattern in each subfamily, and within a subfamily variation is confined to chemically similar residues (alanine/glycine and tyrosine/leucine). Residues in the X2 position in SDL1 and SDL3 pack against SDL2 and contribute to its conformational variation (Fig. 2f–h). SDL1 and SDL3 also bind metal ions (Fig. 2h), and thus their backbone conformations would not be free to vary unless metal ions were lost, but this loss would not be consistent with ligand binding. Switching SDL3 to a β3-like sequence with an alanine-to-arginine substitution abolished pro-TGF-β1 binding and activation, whereas the alanine-to-tyrosine substitution in SDL1 led to partial loss of binding and activation (Fig. 1a,b).
As the outermost and only non-metal-binding SDL, SDL2 has a conformation that has been free to vary in evolution, as shown here in a comparison between integrins with identical α subunits, αVβ3 and αVβ6. Differences stem from the presence of a cis-proline in SDL2 of β3 and packing interactions with X2 residues in SDL1 and SDL3. In agreement with the lack of effect seen here of two SDL2 mutations, only one of the six residues between the two cysteines in SDL2 is identical in β6 and β8 (Fig. 2h), yet αVβ6 and αVβ8 bind and activate pro-TGF-β comparably well (Fig. 1a,b). This supports backbone-dependent contributions of SDL2 to integrin specificity.
Because integrins are important therapeutic targets, the identification of the three SDLs of integrin β subunits not only advances understanding of how β subunits contribute to integrin-ligand specificity but also advances the ability to rationally design antagonists.
ONLINE METHODS
Pro-TGF-β cell-surface binding and activation
αV in a modified pEF1 vector and β1, β3, β5, β6 or β8 mutants in pcDNA3.1 (−) vector were transiently transfected into HEK293T cells11. Purified pro-TGF-β1 (ref. 18) was fluorescently labeled with fluorescein isothiocyanate (FITC) with the Pierce (Thermo Fisher Scientific) FITC labeling kit according to the manufacturer’s instructions. Cells were resuspended in HBS buffer (20 mM HEPES, pH 7.4, 137 mM NaCl, 5 mM KCl, 5.5 mM glucose and 1% bovine serum albumin) and incubated at room temperature for 30 min with 50 nM FITC–pro-TGF-β1 in the presence of 5 mM EDTA, 1 mM Mg2+/Ca2+ or 1 mM Mn2+/0.2 mM Ca2+ and subjected to flow cytometry without washing. To test the expression of different αV integrins, cells were resuspended and incubated at room temperature for 30 min with 2 µg/ml P2W7 antibody (anti-αV, Sigma-Aldrich, cat. no. I6778, monoclonal antibody specific for human integrin αV (160 kDa); validation provided on the manufacturer’s website) and then stained on ice for 30 min with FITC–anti-mouse IgG (1:500) (Sigma-Aldrich). Cells were washed once and subjected to fluorescence flow cytometry. Ligand binding was measured as the mean fluorescence intensity (MFI) of pro-TGF-β1 after subtraction of the MFI in the presence of EDTA.
TGF-β assays used HEK293T cells transiently transfected with the αV and β subunits as above along with wild-type or mutant human pro-TGF-β1 in pcDNA3.1 (−) and then cocultured with transformed mink lung cells expressing a luciferase gene under the control of a TGF-β1–inducible promoter18,32.
αVβ6 and αVβ3 headpiece expression and purification
Soluble αVβ6 headpiece was prepared similarly as in ref. 33. In brief, the αV headpiece (residues 1–594) with the M400C mutation was followed by a 3C protease site, the ACID coiled coil, a strep II tag and a histidine tag. β6 headpiece residues 1–474 with I270C or β3 headpiece residues 1–472 with Q267C were followed by the 3C site, the BASE coiled coil, and a histidine tag. The cysteine mutations generated a disulfide bond that prevented α/β subunit dissociation. Proteins expressed in HEK293S GnTI− cells with Ex-Cell 293 serum-free medium (Sigma) were purified with Ni-NTA affinity columns (Qiagen). Protein was cleaved by 3C protease at 4 °C overnight, passed through Ni-NTA resin and further purified with an ion-exchange gradient from 50 mM to 1 M NaCl, 20 mM Tris-HCl, pH 8.0 (Q fast-flow Sepharose, GE Healthcare) and gel filtration (Superdex 200, GE Healthcare).
Fluorescence anisotropy
Fluorescence anisotropy was in 150 mM NaCl, 1 mM Mg2+/Ca2+, 20 mM HEPES, pH 7.4 or buffer at the indicated pH with 5 nM fluorescence probe (FITC–pro-TGF-β3 peptide, FITC-aminohexanoic-GRGDLGRL). Binding affinities were calculated as described30. In saturation binding assays, the anisotropy of the fluorescence probe was measured while αVβ6 headpiece (starting at 2.67 µM) or αVβ3 headpiece (starting at 75 µM) was serially diluted in three-fold decrements. Competition binding assays used 200 nM αVβ6 or 4 µM αVβ3 headpiece, 5 nM of fluorescent probe, and competing peptide serially diluted in three-fold decrement from 500 µM to 0.5 nM.
Crystallization, data collection and structure determination
Crystals in hanging drops were formed with 3 mg/ml αVβ6 headpiece in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM CaCl2 and 1 mM MgCl2 buffer (1 µl) and 1 µl reservoir solution of 20% PEG 4000, 0.1 M sodium cacodylate, pH 6.0 and 0.2 M ammonium sulfate. Identical v/v mixture of the protein and crystallization buffers yielded a pH of 6.5. Pro-TGF-β3 peptide (1 mM each Ac-HGRGDLGRLKK-NH2, MgCl2, and CaCl2, 0.2 µl) was added to drops of ~1.5 µl (~130 µM final concentration) for 4 h before crystals were harvested. Immediately before flash freezing in liquid N2, crystals were dipped in reservoir solution containing 25% glycerol with or without peptide, MgCl2, and CaCl2, each at 0.25 mM.
Diffraction data from GM/CA-CAT beamline 23-ID of the Advanced Photon Source (APS) at the Argonne National Laboratory were processed with XDS34 with cross-correlation to determine the diffraction limit31. Structures were solved with molecular replacement by PHASER35 with the αVβ3 headpiece from PDB 4G1E as the search model15. The structure was refined with PHENIX36, manually built with Coot, and validated with MolProbity37. I/σI and CC1/2 in the highest-resolution shell increase as a function of the number of diffraction images in plots generated with XDS. The resolution limit was first chosen generously on the basis of CC1/2 of ~10% and after refinement was truncated to the resolution at which CCfree of the highest-resolution shell was ~20% before one final round of refinement was done at the final resolution cutoffs. Furthermore, Rwork/Rfree of the outer shell were 38.0%/41.7% and 36.5%/37.3% for the apo and peptide-soaked models, respectively (Table 1). These results show that the weak diffraction data in the outer shell contribute to structure determination. In the αVβ6-headpiece model (PDB 4UM8), 95.7%, 4.1% and 0.2% of residues have backbone dihedral angles in the favored, allowed, and outlier regions of the Ramachandran plot37, respectively. The MolProbity37 percentile scores are 100 and 100 for clash and geometry, respectively. In the αVβ6 headpiece TGF-β3 peptide complex model (PDB 4UM9), 95.8%, 4.1% and 0.1% of residues are in the favored, allowed and outlier Ramachandran regions, respectively and the MolProbity scores are each in the 98 percentile.
Supplementary Material
Acknowledgments
This work was supported by US National Institutes of Health grant NIH P01HL103526 (T.A.S.).
Footnotes
Accession codes. Coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 4UM8 (αVβ6) and 4UM9 (αVβ6 + TGF-β3 peptide).
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
AUTHOR CONTRIBUTIONS
X.D. contributed to research design, carried out experiments, analyzed data and wrote the manuscript. N.E.H. helped to analyze the data and prepare the manuscript. C.L. contributed research design. T.A.S. conceived the experimental design, analyzed the data and wrote the manuscript.
COMPETINGFINANCIAL INTERESTS
The authors declare no competing financial interests.
References
- 1.Hynes RO. Integrins: bi-directional, allosteric, signaling machines. Cell. 2002;110:673–687. doi: 10.1016/s0092-8674(02)00971-6. [DOI] [PubMed] [Google Scholar]
- 2.Munger JS, et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319–328. doi: 10.1016/s0092-8674(00)80545-0. [DOI] [PubMed] [Google Scholar]
- 3.Mu D, et al. The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1. J. Cell Biol. 2002;157:493–507. doi: 10.1083/jcb.200109100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Shull MM, et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699. doi: 10.1038/359693a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yang Z, et al. Absence of integrin-mediated TGFβ1 activation in vivo recapitulates the phenotype of TGFβ1-null mice. J. Cell Biol. 2007;176:787–793. doi: 10.1083/jcb.200611044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Takagi J, Kamata T, Meredith J, Puzon-McLaughlin W, Takada Y. Changing ligand specificities of αvβ1 and αvβ3 integrins by swapping a short diverse sequence of the β subunit. J. Biol. Chem. 1997;272:19794–19800. doi: 10.1074/jbc.272.32.19794. [DOI] [PubMed] [Google Scholar]
- 7.Xiong JP, et al. Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science. 2002;296:151–155. doi: 10.1126/science.1069040. [DOI] [PubMed] [Google Scholar]
- 8.Xiao T, Takagi J, Wang J-h, Coller BS, Springer TA. Structural basis for allostery in integrins and binding of fibrinogen-mimetic therapeutics. Nature. 2004;432:59–67. doi: 10.1038/nature02976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Nagae M, et al. Crystal structure of α5β1 integrin ectodomain: atomic details of the fibronectin receptor. J. Cell Biol. 2012;197:131–140. doi: 10.1083/jcb.201111077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sen M, Yuki K, Springer TA. An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2. J. Cell Biol. 2013;203:629–642. doi: 10.1083/jcb.201308083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wang R, et al. GARP regulates the bioavailability and activation of TGF-β. Mol. Biol. Cell. 2012;23:1129–1139. doi: 10.1091/mbc.E11-12-1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ludbrook SB, Barry ST, Delves CJ, Horgan CM. The integrin αvβ3 is a receptor for the latency-associated peptides of transforming growth factors β1 and β3. Biochem. J. 2003;369:311–318. doi: 10.1042/BJ20020809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Xiong J-P, et al. Crystal structure of the extracellular segment of integrin αVβ3. Science. 2001;294:339–345. doi: 10.1126/science.1064535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Zhu J, et al. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol. Cell. 2008;32:849–861. doi: 10.1016/j.molcel.2008.11.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Dong X, et al. αVβ3 integrin crystal structures and their functional implications. Biochemistry. 2012;51:8814–8828. doi: 10.1021/bi300734n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhu J, Zhu J, Springer TA. Complete integrin headpiece opening in eight steps. J. Cell Biol. 2013;201:1053–1068. doi: 10.1083/jcb.201212037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Paroutis P, Touret N, Grinstein S. The pH of the secretory pathway: measurement, determinants, and regulation. Physiology (Bethesda) 2004;19:207–215. doi: 10.1152/physiol.00005.2004. [DOI] [PubMed] [Google Scholar]
- 18.Shi M, et al. Latent TGF-β structure and activation. Nature. 2011;474:343–349. doi: 10.1038/nature10152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Acharya R, et al. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature. 1989;337:709–716. doi: 10.1038/337709a0. [DOI] [PubMed] [Google Scholar]
- 20.Takagi J, Petre BM, Walz T, Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110:599–611. doi: 10.1016/s0092-8674(02)00935-2. [DOI] [PubMed] [Google Scholar]
- 21.Springer TA, Zhu J, Xiao T. Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin αIIbβ3 . J. Cell Biol. 2008;182:791–800. doi: 10.1083/jcb.200801146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Parise LV, Helgerson SL, Steiner B, Nannizzi L, Phillips DR. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb–IIIa. J. Biol. Chem. 1987;262:12597–12602. [PubMed] [Google Scholar]
- 23.Frelinger AL, et al. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J. Biol. Chem. 1988;263:12397–12402. [PubMed] [Google Scholar]
- 24.Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc. Natl. Acad. Sci. USA. 1985;82:8057–8061. doi: 10.1073/pnas.82.23.8057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mas-Moruno C, Rechenmacher F, Kessler H. Cilengitide: the first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation. Anticancer Agents Med. Chem. 2010;10:753–768. doi: 10.2174/187152010794728639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Schürpf T, Springer TA. Regulation of integrin affinity on cell surfaces. EMBO J. 2011;30:4712–4727. doi: 10.1038/emboj.2011.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Springer TA, Dustin ML. Integrin inside-out signaling and the immunological synapse. Curr. Opin. Cell Biol. 2012;24:107–115. doi: 10.1016/j.ceb.2011.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Takagi J, Debottis DP, Erickson HP, Springer TA. The role of specificity-determining loop of the integrin β-subunit I-like domain in folding, association with the α subunit, and ligand binding. Biochemistry. 2002;41:4339–4347. doi: 10.1021/bi016047u. [DOI] [PubMed] [Google Scholar]
- 29.Huhtala M, Heino J, Casciari D, de Luise A, Johnson MS. Integrin evolution: insights from ascidian and teleost fish genomes. Matrix Biol. 2005;24:83–95. doi: 10.1016/j.matbio.2005.01.003. [DOI] [PubMed] [Google Scholar]
- 30.Rossi AM, Taylor CW. Analysis of protein-ligand interactions by fluorescence polarization. Nat. Protoc. 2011;6:365–387. doi: 10.1038/nprot.2011.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Karplus PA, Diederichs K. Linking crystallographic model and data quality. Science. 2012;336:1030–1033. doi: 10.1126/science.1218231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Abe M, et al. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 1994;216:276–284. doi: 10.1006/abio.1994.1042. [DOI] [PubMed] [Google Scholar]
- 33.Yu Y, Schurpf T, Springer TA. How natalizumab binds and antagonizes α4 integrins. J. Biol. Chem. 2013;288:32314–32325. doi: 10.1074/jbc.M113.501668. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kabsch W. In: International Tables for Crystallography. Rossmann MG, Arnold E, editors. Ch. 25.2.9. Kluwer: Academic Publishers; 2001. pp. 730–734. Vol. F. [Google Scholar]
- 35.McCoy AJ, et al. Phaser crystallographic software. J. Appl. Crystallogr. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Adams PD, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Davis IW, et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007;35:W375–W383. doi: 10.1093/nar/gkm216. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.